GGrantIndex
← Search

Genome Editing

$124,339P30FY2023CANIH

Rutgers Biomedical And Health Sciences, Newark NJ

Investigators

Linked publications, trials & patents

Trial NCT05639972Trial NCT05483491Trial NCT05296421Trial NCT04929015Trial NCT04920344Trial NCT04871516Trial NCT04751747Trial NCT04445844Trial NCT04294264Trial NCT04285268Trial NCT04253483Trial NCT04211259Trial NCT04179227Trial NCT04163952Trial NCT04146038Trial NCT04081688Trial NCT03902379Trial NCT03725449Trial NCT03677739Trial NCT03456843Trial NCT03448224Trial NCT03441321Trial NCT03428802Trial NCT03272633Trial NCT03257163Trial NCT03233555Trial NCT03229278Trial NCT03228147Trial NCT03112668Trial NCT03108911Trial NCT03102060Trial NCT03061175Trial NCT03028948Trial NCT02949284Trial NCT02885649Trial NCT02748564Trial NCT02699996Trial NCT02688517Trial NCT02688192Trial NCT02621398Trial NCT02526511Trial NCT02526498Trial NCT02458716Trial NCT02421575Trial NCT02420652Trial NCT02324621Trial NCT02324608Trial NCT02315196Trial NCT02295540Trial NCT02294617Trial NCT02250781Trial NCT02203604Trial NCT02203578Trial NCT02177838Trial NCT02144701Trial NCT02144675Trial NCT02105116Trial NCT01828476Trial NCT01694589Trial NCT01652014Trial NCT01649947Trial NCT01480154Trial NCT01417286Trial NCT01407562Trial NCT01303341Trial NCT01251172Trial NCT01032590Trial NCT01018836Trial NCT01009931Trial NCT01006369Trial NCT00996359Trial NCT00991315Trial NCT00966667Trial NCT00962845Trial NCT00946283Trial NCT00943709Trial NCT00939380Trial NCT00934895Trial NCT00909909Trial NCT00905918Trial NCT00900120Trial NCT00899808Trial NCT00899639Trial NCT00895115Trial NCT00891969Trial NCT00878657Trial NCT00866840Trial NCT00853125Trial NCT00813423Trial NCT00786682Trial NCT00770419Trial NCT00770055Trial NCT00769652Trial NCT00765765Trial NCT00749437Trial NCT00740805Trial NCT00728845Trial NCT00726596Trial NCT00669734Trial NCT00667901

Abstract

! GENOME EDITING SHARED RESOURCE PROJECT SUMMARY/ABSTRACT Mouse models of human cancer are instrumental in understanding tumorigenesis. Advances continue to be made that allow better understanding of the mechanisms of tumor development, which leads toward the identification of new diagnostics and therapies. The Genome Editing shared resource at Rutgers Cancer Institute of New Jersey (CINJ) was established in 2016 as a consortium managed shared resource whose purpose is to provide a centralized laboratory for the generation and preservation of mouse research models and creation of custom genome edited cell lines. The services offered by the Genome Editing shared resource ensure that investigators across the consortium are equipped to make scientific breakthroughs and speed research into mechanisms of cancer initiation, progression and treatment using genetically engineered mouse models (GEMMs) and genetically modified human and mouse cell lines. The considerable experience and technical expertise of the managing and scientific directors are also a valuable resource made available to investigators. Moreover, Genome Editing offers cryopreservation of research mouse models to safeguard against devastating loss of investigators’ valuable GEMM lines. Almost all of the procedures conducted by the shared resource require a high degree of technical expertise and equipment not readily available to individual laboratories. In addition to its service functions, the Genome Editing shared resource plays an important intellectual role in the development and pursuit of mouse-oriented research projects and the application of genome editing throughout the CINJ consortium. The shared resource also engages in the development of new approaches and methodologies in genome editing to better serve its users.

View original record on NIH RePORTER →